Eight mutual fund New Fund Offers (NFOs) opened for subscription this week, with five funds launching on August 17 and three additional schemes following later in the week. According to reports from ACE MF, the new offerings span hybrid, debt, commodity and sectoral categories, with minimum investment amounts ranging from ₹100 to ₹5,000. The schemes include Nippon India Income Plus Arbitrage Omni FOF, Quant Income Plus Arbitrage Active FoF, ITI Multi Asset Allocation Fund, Quant Silver ETF, Edelweiss Ultra Short Term Fund, Invesco India Pharma and Healthcare Fund, and DSP Financial Services Sectoral Debt Fund.
Two fund-of-funds schemes lead the NFO lineup with ₹5,000 minimum investment requirements. As reported by ACE MF, Nippon India Income Plus Arbitrage Omni FOF and Quant Income Plus Arbitrage Active FoF both fall under the domestic fund-of-funds category within hybrid schemes, with subscription periods running from August 17 to August 31. The ITI Multi Asset Allocation Fund also requires ₹5,000 minimum investment and belongs to the Hybrid – Multi Asset Allocation category, with its NFO closing on August 31. Additionally, Quantum Flexi Cap Fund will open for subscription on August 21 and close on September 4, requiring a ₹500 minimum application amount.
Quant Silver ETF represents the shortest-duration NFO among the five, requiring a ₹2,000 minimum investment and closing on August 19. According to ACE MF, this scheme falls under the Silver ETF category. Edelweiss Ultra Short Term Fund offers the most accessible entry point with the lowest minimum investment of ₹100 and remains open until August 24. The fund is classified under Debt – Ultra Short Duration Fund category. DSP Financial Services Sectoral Debt Fund will open for subscription on August 17 and close on August 24, requiring a ₹100 minimum application amount.
Invesco India Pharma and Healthcare Fund will open for subscription on August 18 and close on September 1, requiring a ₹1,000 minimum application amount. As reported by ACE MF, this scheme falls under the Healthcare category, providing investors with sectoral exposure to the pharmaceutical and healthcare sector. The fund house launches new funds to complete their bouquet of offerings, with these schemes designed to complement existing product portfolios across different investment categories and risk profiles.
As reported by ACE MF, investors should remember that NFOs represent new schemes and require careful evaluation before investment. The publication emphasizes that investors should consider the scheme's objective, asset allocation, risk level, costs and whether it fits their financial goals and portfolio. The minimum investment amounts range from ₹100 to ₹5,000, providing options for various investor categories and investment preferences across the eight available schemes. Fund houses launch new funds to complete their bouquet of offerings, ensuring comprehensive product portfolios for different investor segments.
